{"name":"Ubix Therapeutics, Inc.","slug":"ubix-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"UBX-303061","genericName":"UBX-303061","slug":"ubx-303061","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"UBX-303061","genericName":"UBX-303061","slug":"ubx-303061","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxNNVF1QWFHMzlsLVg3UEU2NUFqalY0WmpQRGxrdWt6XzduZ1B3aXpOLWlKczQ0OWE1Q2QwbFlOVU9DcktxYUZoQmdzcERXSWI3NVlRNVhqeFM4MkMzV096X3FVR2Y4Rlp5VWlGVkwyd3BPZjhCMGFzLThKSFNqRTQ1eEhaNUhfdG1EQjhNUXhCczJ3anVvaUlIRFYwOUpwdUQtazNxSW1QcG4zUmFnQVJUSlVQT3Q?oc=5","date":"2025-09-01","type":"pipeline","source":"BioSpectrum Asia","summary":"Unlocking the Undruggable with Targeted Protein Degradation - BioSpectrum Asia","headline":"Unlocking the Undruggable with Targeted Protein Degradation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxQdjI4X0ZmMTlKdFJyUS1xM0ZMdEJoSHBVSHRWRWJqdWpDeW5GempiM0ZYVTh0dXBONTZMcWNlRUo1OUt0ZjlyckJQSG1xb216MzlCUG8xYkt0cml2aW1MNzloYVZMN0t2THJfMzVxSzQ2QW9Rd1RjZjdEbUhCTmU0Q29GLWNLekZiQ19vTWFKb1lLR2oyelNyX2ZUaTRoTzJGQUhfeTg1TnBjUlR3bVhkUG1ORWJyRWNRSzhxTFZQWXE1VDdtcHR5NmRneXpNOWdVUTFWSWdsUFRxNXhtbWFGdQ?oc=5","date":"2025-05-15","type":"deal","source":"BioSpectrum Asia","summary":"Agilent partners with Ubix Therapeutics to advance transformative cancer research in South Korea - BioSpectrum Asia","headline":"Agilent partners with Ubix Therapeutics to advance transformative cancer research in South Korea","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE1xTGYzVWtVVTNBR3hkVEgyTUE5QXhiUFNkRk10UXJPaFA0eHBWTXp5TlducV9hNTdILUVyYzd6VWNKUWlLQ3lGNUUtMW9JQkVxYUFYTjBTX2hPcFVnQl9tcjByWVRtSGhBM2w2Q1B30gFyQVVfeXFMTnVucTh2R3dwVWxVRGRBSTd4QTlTbTFjeVVlM184VHJNSURWT016eHpwOVdWNERqNUpXZnprSjQyU3g3cnZVNGpqLWMweUVFVE12V01VNGJfU2xvdDhWOGxlMXBhUHJGYTNmcDY3cmJCNy1B?oc=5","date":"2025-04-30","type":"pipeline","source":"koreabiomed.com","summary":"Ubix Therapeutics accelerates TPD development with BTK target, eyes IPO in 2025 - koreabiomed.com","headline":"Ubix Therapeutics accelerates TPD development with BTK target, eyes IPO in 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE5TdXdUTmM5ZTY3aS14am9vTGtZUHcyZ2NPbDJBTU9BRWFXQmtJSjlHU0ZBZkktMnFCM2t3WWE1VkoybW1Xcng3ZmJ4OUlWMk0zTnRtbU1Id3JNQWEwZl9BT0xLcHJiMDA0d1V4MDRB0gFyQVVfeXFMTWdIZjRGRjc3SElvODVfSnhrUHFmbWhCSW1GVlh5ZEpDdnZwc045aFNHcDJGeHJ5U2FXZlZLT0JZZ241SVJ5MU1HR0xJWVFqc3F5UXJmeGFNZ1h3blZTbVZGVGdlbEJlV0VtOW9GNXlsQlp3?oc=5","date":"2025-04-21","type":"pipeline","source":"koreabiomed.com","summary":"Korean pharma acclerates TPD and DAC development amid global interest in new drug madalities - koreabiomed.com","headline":"Korean pharma acclerates TPD and DAC development amid global interest in new drug madalities","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUkFVX3lxTFB5WWF5cElrcmFfREZvVVZrbEpBYmdWeGRsY0FSSmRBY0h4QnFtcHhWUjVuX3FwMV9HM2c1MVRjSUxJT3AtVWdiRjY5dVhRUy01aUE?oc=5","date":"2025-02-26","type":"pipeline","source":"venturesquare.net","summary":"Wybio and Ubix Therapeutics Sign New Drug Joint Research Agreement - venturesquare.net","headline":"Wybio and Ubix Therapeutics Sign New Drug Joint Research Agreement","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE1KLXJONmhZTGNKOGRXaFg2RGpsRFdUVy1feWUzUjM1bWxhOUdWdzZGTmg1aWJqR05vU3YxeVMxclBZMjI4YXRWZXV6aGtfR2d0TU80UmZHZWRZcVlBVWlSdXF0TTlvSmhrMW9FdDJn0gFyQVVfeXFMT1lUZVl5VG1INUNFXzFWQ0U0ckxqTWh4ejFxOEFDb2NBM1JkT1pkT0lCTW53M1B6YlRCaUdaOUw2cW5aenJjNmo4UzNsUmUwTVFVQk01S25ObUFLMTE4RE00VDhUUGxfdmYtOUwtU25yd0lB?oc=5","date":"2024-12-24","type":"pipeline","source":"koreabiomed.com","summary":"Ubix Therapeutics draws ₩25.7 million pre-IPO funding - koreabiomed.com","headline":"Ubix Therapeutics draws ₩25.7 million pre-IPO funding","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE1HMVFaN0Q5YXFVaTlIUGY5SHAxcjZaaFNhQU5iWHl5dVIyeFlQSnF5eXZxcVRXYTQ0eVJjcVl4YWhRaHRzQjd5RW5WMjI2cHg0M25NOXdWUkFLeURpRUxHenNnZ21DZ3BTNW5OTFBn0gFyQVVfeXFMTk10dWs1WHFWYkVhZEV5SEQ2bGEzOWpEbFgxX1lfMlh0aS05dHNRLXhUSE5LUk1oeFgwUjBoSlFoSE1hVXVHel8tN3BsS05ZRk5oQmNwNVdJT1lGclpQSzhuWXN2dXdSbVF0R184LXJUUGdR?oc=5","date":"2024-10-17","type":"pipeline","source":"koreabiomed.com","summary":"[Health Innovation②] JLABS introduces ‘No Strings Attached’ model to Korean biotech startups - koreabiomed.com","headline":"[Health Innovation②] JLABS introduces ‘No Strings Attached’ model to Korean biotech startups","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE9xT1pQU0tLbmk5Y1FoeW9INnBCdUdrcTlxckJQVE8yN1hsaG56azF6YmpmRlctUVNEOUMxT29mUVNvM1RRLVRqVHJFV3lQSDlJSVFsY0lPRjFxN2pMS3pRQWpJbzJDZU9IaVpYSlNn0gFyQVVfeXFMTjVJRFZxQ3UwVlJ4Y3Vpaks4ZXBwRE5lOVphaDVDMDIxOHZ1X0kyS3dCdmNGU2JDN1l6ZExERGFHcXlhSWVTZGV1QzlkbFdJS1dUZWZibjA2ckpsaTVHRWlwYzRTWnlXS2FwV2U2NG1TbGt3?oc=5","date":"2024-07-02","type":"pipeline","source":"koreabiomed.com","summary":"Yuhan secures global rights to Ubix Therapeutics' prostate cancer treatment - koreabiomed.com","headline":"Yuhan secures global rights to Ubix Therapeutics' prostate cancer treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisANBVV95cUxQbTBERjVJZHdHR3h6TXVJc0Vrdm13SlFHWkRYY2lrMFFMTURpM2RQUkVvR1A2TVlaZl95Ul85REhuZFNlSEZ0ZXBUZzBjbDZVazd5TFJsQ0JGWWlxRGlvQjJ3N1N4VUhDSHNraTdfNmh4cl9oUTdOZFZIanIxMkNyQ0NZNWFjel91ZkdSd2g0b1RRcVVacEJRRGhKRkVZcmR0aFNKOGZiZGxFeXRoMVdqem8ySV9sWG9OUHg1RXBXbThIemd1dzdJbEpwc0o4c3JhOGVzU3B6NUhOdEdEcEV0clNJNE1VMk1rbGFzQjFaV3pralFOTDBJYUJaUkltdnBnLTM5WElaUjJlRzI4YW9FXzQwNFdNMVJORkRfNHROX1RUVjNHWGVFT3VlRFJ4Y3B5VF9vdUVGdy1kc2Q5VEJ6a010QXd0dmNmYUhNcm5ia18ycGRxQldaeklBbHJRMVliZGVNZHVIVWtKTUhITDZtN3NsdFEwZ0taVVJVSkx0c2JGbC1MektSeDdzczQyZ000WkxXcXZVSHNraDc1TEx3WG5CZmJaRlp2eUNmVVFpTFo?oc=5","date":"2023-05-31","type":"trial","source":"GlobeNewswire","summary":"B-Cell Lymphoma Clinical Trial Pipeline Insights: - GlobeNewswire","headline":"B-Cell Lymphoma Clinical Trial Pipeline Insights:","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}